Eli Lilly and Company News - July 15, 2026

Novo Nordisk wins EU approval for oral Wegovy, first GLP-1 pill

The European Commission approved Novo Nordisk’s once-daily oral version of Wegovy. This is the first oral GLP-1 treatment for weight management in the European...